跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Recombinant Type I Herpes Simplex Virus Vector
首页
药物
Recombinant Type I Herpes Simplex Virus Vector
Recombinant Type I Herpes Simplex Virus Vector
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Recombinant herpes simplex virus type 2 and its preparing method and use
CN 1844376 A
申请人: UNIV WUHAN
优先权: 2006
CN
Herpes simplex virus I-type gene recombinant attenuated live vaccine and preparation method thereof
CN 102657861 A
申请人: ZHENGZHOU GENECINE BIOENGINEERING CO LTD
优先权: 2010
CN
I-type herpes simplex virus vector and recombinant oncolytic I-type herpes simplex virus
CN 112575036 A
申请人: IMMVIRA CO LTD
优先权: 2016
CN
Recombinant DNA vaccine formed by serially connecting gB and gD antigen epitopes of herpes simplex virus type I
CN 118178635 A
申请人: SHENYANG AIER ZHUOYUE EYE HOSPITAL CO LTD
优先权: 2024
CN
ENGINEERED HERPES SIMPLEX VIRUS VECTOR FOR IMPROVING STRUCTURE AND FUNCTIONS OF SKIN, AND USE THEREOF
WO 2026179887 A1
申请人: BEIJING WELLGENE BIOTECH CO LTD
优先权: 2025
WO
药物
反馈
